The drugs work by increasing satiety (making people feel full sooner) and suppressing the appetite so they do not feel as hungry. They also improve glycemic control and reduce blood sugar levels. They are one of the most effective treatments available in the battle against obesity and the health problems and early deaths associated with obesity.

The STEP (Semaglutide Treatment Effect in People with Obesity) trials consistantly showed a 15% reduction in weight over 68 weeks.

Another study, Major Adverse Cardiovascular Events (MACE), found that semaglutide significantly reduced the risk of cardivascular (CVD) events such as heart attacks, strokes, and CVD-related deaths.

Semaglutide can be given by injection once a week or by daily pills (brand name Rybelsus only, no compounding). Terzepitide is only injection. To qualify you must have a BMI of > 30. If you have medical insurance that will pay for the medication we will try to help you get it approved by insurance. Semaglutide is available as a cheaper compounded injection as the FDA has declared a shortage of the medication. Terzepitide is only availabe as a brand name product (Zepbound) as the FDA took it off the shortage list.